Quoted from http://www.reuters.com/article/marketsNews/idINN1046473820090610?rpc=44
US FDA panel backs antipsychotic drugs for kids
Wed Jun 10, 2009 4:47pm EDT
By Susan Heavey
ADELPHI, Md., June 10 (Reuters) - Three widely used antipsychotic medications appear safe and effective overall in treating children and teenagers with schizophrenia or bipolar disorder, a U.S. advisory panel said on Wednesday.
The Food and Drug Administration's panel of outside experts backed wider use of the pills -- Eli Lilly and Co's (LLY.N) Zyprexa, AstraZeneca's (AZN.L) Seroquel and Pfizer's (PFE.N) Geodon -- but expressed concern over long-term effects the medications may have in younger patients....
"I'm concerned about the lack of true long-term studies" especially in younger patients "who will have a long lifetime, hopefully," said panel member Ruth Day, a researcher at Duke University.